Metformin Induces a Caspase 3-Unrelated Apoptosis in Human Colorectal Cancer Cell Lines HCT116 and SW620

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Xie Y-H, Chen Y-X, Fang J-Y. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5(1):22. doi:10.1038/s41392-020-0116-z
   PubMed Web of Science ®Google Scholar
• Aoullay Z, Slaoui M, Razine R, Er-Raki A, Meddah B, Cherrah Y. Therapeutic characteristics, chemotherapy-related toxicities and survivorship in colorectal cancer patients. Ethiop J Health Sci. 2020;30(1):65–74. doi:10.4314/ejhs.v30i1.9
   PubMed Web of Science ®Google Scholar
• An H, He L. Current understanding of metformin effect on the control of hyperglycemia in diabetes. J Endocrinol. 2016;228(3):R97–R106. doi:10.1530/JOE-15-0447
   PubMed Web of Science ®Google Scholar
• Viollet B, Guigas B, Garcia NS, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci. 2012;122(6):253–270. doi:10.1042/CS20110386
   PubMed Web of Science ®Google Scholar
• Madiraju AK, Erion DM, Rahimi Y, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510(7506):542–546. doi:10.1038/nature13270
   PubMed Web of Science ®Google Scholar
• Madiraju AK, Qiu Y, Perry RJ, et al. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med. 2018;24(9):1384–1394. doi:10.1038/s41591-018-0125-4
   PubMed Web of Science ®Google Scholar
• Goodwin P, Pritchard K, Ennis M, Clemons M, Graham M, Fantus IG. Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer. 2008;8(6):501–505. doi:10.3816/CBC.2008.n.060
   PubMed Web of Science ®Google Scholar
• Dowling RJO, Goodwin PJ, Stambolic V. Understanding the benefit of metformin use in cancer treatment. BMC Med. 2011;9:33. doi:10.1186/1741-7015-9-33
   PubMed Web of Science ®Google Scholar
• Safe S, Nair V, Karki K. Metformin-induced anticancer activities: recent insights:. Biol Chem. 2018;399(4):321–335. doi:10.1515/hsz-2017-0271
   PubMed Web of Science ®Google Scholar
• Aljofan M, Riethmacher D. Anticancer activity of metformin: a systematic review of the literature. Futur Sci OA. 2019;5(8):FSO410–FSO410. doi:10.2144/fsoa-2019-0053
   PubMed Web of Science ®Google Scholar
• Currie CJ, Poole CD, Gale EAM. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009;52(9):1766–1777. doi:10.1007/s00125-009-1440-6
   PubMed Web of Science ®Google Scholar
• Miyoshi H, Kato K, Iwama H, et al. Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo. Int J Oncol. 2014;45(1):322–332. doi:10.3892/ijo.2014.2419
   PubMed Web of Science ®Google Scholar
• Qu Z, Zhang Y, Liao M, Chen Y, Zhao J, Pan Y. In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma. Hepatol Res. 2012;42(9):922–933. doi:10.1111/j.1872-034X.2012.01007.x
   PubMed Web of Science ®Google Scholar
• Xiong Y, Lu Q-J, Zhao J, Wu G-Y. Metformin inhibits growth of hepatocellular carcinoma cells by inducing apoptosis via mitochondrion-mediated pathway. Asian Pacific J Cancer Prev. 2012;13(7):3275–3279. doi:10.7314/APJCP.2012.13.7.3275
   PubMedGoogle Scholar
• Queiroz EAIF, Puukila S, Eichler R, et al. Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. PLoS One. 2014;9(5):e98207. doi:10.1371/journal.pone.0098207
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Miskimins WK. Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27(Kip1) or p21(Cip1). J Mol Signal. 2008;3:18. doi:10.1186/1750-2187-3-18
   PubMedGoogle Scholar
• Wang J, Gao Q, Wang D, Wang Z, Hu C. Metformin inhibits growth of lung adenocarcinoma cells by inducing apoptosis via the mitochondria‑mediated pathway. Oncol Lett. 2015;10(3):1343–1349. doi:10.3892/ol.2015.3450
   PubMed Web of Science ®Google Scholar
• Wang L-W, Li Z-S, Zou D-W, Jin Z-D, Gao J, Xu G-M. Metformin induces apoptosis of pancreatic cancer cells. World J Gastroenterol. 2008;14(47):7192–7198. doi:10.3748/wjg.14.7192
   PubMed Web of Science ®Google Scholar
• Buzzai M, Jones RG, Amaravadi RK, et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 2007;67(14):6745–6752. doi:10.1158/0008-5472.CAN-06-4447
   PubMed Web of Science ®Google Scholar
• Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 1981;41(5):1751–1756.
   PubMed Web of Science ®Google Scholar
• Leibovitz A, Stinson JC, McCombs WB, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976;36(12):4562–4569.
   PubMed Web of Science ®Google Scholar
• Ahmed D, Eide PW, Eilertsen IA, et al. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013;2(9):e71. doi:10.1038/oncsis.2013.35
   PubMedGoogle Scholar
• Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991;3(7):207–212. doi:10.3727/095535491820873191
   PubMed Web of Science ®Google Scholar
• Riss TL, Moravec RA. Comparison of MTT, XTT, and a novel tetrazolium compound MTS for in vitro proliferation and chemosensitivity assays. Mol Biol Cell. 1992;3(Suppl):184A–184A.
   Google Scholar
• Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315–2319. doi:10.1038/nprot.2006.339
   PubMed Web of Science ®Google Scholar
• Munshi A, Hobbs M, Meyn RE. Clonogenic cell survival assay. In: Chemosensitivity. Springer; 2005:021–028.
   Google Scholar
• Niles AL, Moravec RA, Riss TL. Caspase activity assays. Methods Mol Biol. 2008;414:137–150. doi:10.1007/978-1-59745-339-4_11
   PubMedGoogle Scholar
• Idziorek T, Estaquier J, De Bels F, Ameisen JC. YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J Immunol Methods. 1995;185(2):249–258. doi:10.1016/0022-1759(95)00172-7
   PubMed Web of Science ®Google Scholar
• Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006;66(21):10269–10273. doi:10.1158/0008-5472.CAN-06-1500
   PubMed Web of Science ®Google Scholar
• Voit R, Hoffmann M, Grummt I. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J. 1999;18(7):1891–1899. doi:10.1093/emboj/18.7.1891
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680. doi:10.1038/227680a0
   PubMed Web of Science ®Google Scholar
• McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 2013;5(4):a008656. doi:10.1101/cshperspect.a008656
   PubMed Web of Science ®Google Scholar
• Parrish AB, Freel CD, Kornbluth S. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol. 2013;5(6):a008672. doi:10.1101/cshperspect.a008672
   PubMed Web of Science ®Google Scholar
• Powolny A, Xu J, Loo G. Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53. Int J Biochem Cell Biol. 2001;33:193–203. doi:10.1016/S1357-2725(00)00080-7
   PubMed Web of Science ®Google Scholar
• Samaha HS, Asher E, Payne CM, Bernstein C, Bernstein H. Evaluation of cell death in EBV-transformed lymphocytes using agarose gel electrophoresis, light microscopy and electron microscopy. I. Induction of classic apoptosis by the bile salt, sodium deoxycholate. Leuk Lymphoma. 1995;19(1–2):95–105. doi:10.3109/10428199509059663
   PubMed Web of Science ®Google Scholar
• Duriez PJ, Shah GM. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol. 1997;75(4):346–347. doi:10.1139/o97-043
   Web of Science ®Google Scholar
• Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376(6535):37–43. doi:10.1038/376037a0
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem. 1994;269(49):30761–30764. doi:10.1016/S0021-9258(18)47344-9
   PubMed Web of Science ®Google Scholar
• Sadeghi H, Yazdanparast R. Isolation and structure elucidation of a new potent anti-neoplastic diterpene from Dendrostellera lessertii. Am J Chin Med. 2005;33(5):831–837. doi:10.1142/S0192415X05003387
   PubMed Web of Science ®Google Scholar
• Bailey CJ. Metformin: historical overview. Diabetologia. 2017;60(9):1566–1576. doi:10.1007/s00125-017-4318-z
   PubMed Web of Science ®Google Scholar
• Nasri H, Rafieian-Kopaei M. Metformin: current knowledge. J Res Med Sci. 2014;19(7):658–664.
   PubMed Web of Science ®Google Scholar
• Sui X, Xu Y, Wang X, Han W, Pan H, Xiao M. Metformin: a novel but controversial drug in cancer prevention and treatment. Mol Pharm. 2015;12(11):3783–3791. doi:10.1021/acs.molpharmaceut.5b00577
   PubMedGoogle Scholar
• Martin-Montalvo A, Mercken EM, Mitchell SJ, et al. Metformin improves healthspan and lifespan in mice. Nat Commun. 2013;4:2192. doi:10.1038/ncomms3192
   PubMed Web of Science ®Google Scholar
• Pryor R, Cabreiro F. Repurposing metformin: an old drug with new tricks in its binding pockets. Biochem J. 2015;471(Pt 3):307–322. doi:10.1042/BJ20150497
   PubMedGoogle Scholar
• Podhorecka M, Ibanez B, Dmoszyńska A. Metformin - its potential anti-cancer and anti-aging effects. Postepy Hig Med Dosw. 2017;71:170–175.
   PubMed Web of Science ®Google Scholar
• Fujisawa S, Romin Y, Barlas A. Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases. Cytotechnology Mar Pp. 2014;66:259–273. doi:10.1007/s10616-013-9565-3
   PubMed Web of Science ®Google Scholar
• Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6(2):99–104. doi:10.1038/sj.cdd.4400476
   PubMed Web of Science ®Google Scholar
• Ben-Sahra I, Laurent K, Loubat A, et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene. 2008;27:3576. doi:10.1038/sj.onc.1211024
   PubMed Web of Science ®Google Scholar
• Alimova IN, Liu B, Fan Z, et al. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle. 2009;8(6):909–915. doi:10.4161/cc.8.6.7933
   PubMed Web of Science ®Google Scholar
• Isakovic A, Harhaji L, Stevanovic D, et al. Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell Mol Life Sci. 2007;64(10):1290–1302. doi:10.1007/s00018-007-7080-4
   PubMed Web of Science ®Google Scholar
• Tang J-C, An R, Jiang YQ, Yang J. Effects and mechanisms of metformin on the proliferation of esophageal cancer cells in vitro and in vivo. Cancer Res Treat. 2016;49(3):778–789. doi:10.4143/crt.2015.485
   PubMed Web of Science ®Google Scholar
• Takahashi A, Kimura F, Yamanaka A, et al. Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis. Cancer Cell Int. 2014;14(1):1–12. doi:10.1186/1475-2867-14-53
   PubMedGoogle Scholar
• Shi WY, Xiao D, Wang L, et al. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis. 2012;3(3):e275–9. doi:10.1038/cddis.2012.13
   PubMedGoogle Scholar
• Tomic T, Botton T, Cerezo M, et al. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis. 2011;2(9):e199–10. doi:10.1038/cddis.2011.86
   PubMedGoogle Scholar
• Han G, Gong H, Wang Y, Guo S, Liu K. AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell. Cancer Biol Ther. 2015;16(1):77–87. doi:10.4161/15384047.2014.987021
   PubMed Web of Science ®Google Scholar
• Lu CC, Chiang JH, Tsai FJ, et al. Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signalling. Int J Oncol. 2019;54(4):1271–1281. doi:10.3892/ijo.2019.4704
   PubMed Web of Science ®Google Scholar
• Zhao Y, Luo Q, Mo J, et al. Metformin in combination with JS-K inhibits growth of renal cell carcinoma cells via reactive oxygen species activation and inducing DNA breaks. J Cancer. 2020;11(13):3701–3712. doi:10.7150/jca.36372
   PubMed Web of Science ®Google Scholar
• Alhourani AH, Tidwell TR, Bokil AA, et al. Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells. Sci Rep. 2021;11(1):10487. doi:10.1038/s41598-021-89861-6
   PubMed Web of Science ®Google Scholar
• Quentin T, Steinmetz M, Poppe A, Thoms S. Metformin differentially activates ER stress signaling pathways without inducing apoptosis. Dis Model Mech. 2012;5(2):259–269. doi:10.1242/dmm.008110
   PubMed Web of Science ®Google Scholar
• Cha J-H, Yang W-H, Xia W, et al. Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1. Mol Cell. 2018;71(4):606–620.e7. doi:10.1016/j.molcel.2018.07.030
   PubMed Web of Science ®Google Scholar